ProAssurance Corporation
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Edward Lewis Rand Jr.
- Full Time Employees
- 1,036
- Sector
- Financial Services
- Industry
- Insurance - Property & Casualty
- Address
- 100 Brookwood Place Birmingham AL United States of America 35209
- IPO Date
- Sep 4, 1991
- CIK
- 0001127703
- Website
- proassurance.com
- Similar Companies
- Business
- ProAssurance Corporation is an industry-leading specialty property and casualty insurance company primarily engaged in providing professional liability insurance across the United States. Founded in 1976 and headquartered in Birmingham, Alabama, ProAssurance offers a broad array of insurance products including medical professional liability insurance for healthcare providers and institutions; medical technology liability insurance for medical technology and life sciences companies that manufacture or distribute products and conduct clinical trials; legal professional liability insurance for attorneys and their firms; and workers' compensation insurance products such as guaranteed cost policies, retrospectively rated policies, and deductible policies. The company also delivers custom alternative risk solutions including assumed reinsurance, loss portfolio transfers, and captive cell programs targeted at healthcare professional liability insureds. Additional services include program design, fronting, claims administration, risk management, and asset management marketed through independent agencies, brokers, and an internal business development team. Recent major developments include ProAssurance's definitive agreement to be acquired by The Doctors Company, the nation’s largest physician-owned medical malpractice insurer. This transaction, expected to close in the first half of 2026 pending stockholder and regulatory approvals, will make ProAssurance a wholly owned subsidiary of The Doctors Company and will create a combined entity with approximately $12 billion in assets. This acquisition represents a significant strategic expansion aimed at enhancing the scale and capabilities to serve healthcare professionals nationwide. The deal aligns with both companies’ histories, operating philosophies, and mission to protect healthcare providers through specialized insurance solutions. ProAssurance maintains a strong industry presence with a focus on healthcare, medical technology, life sciences, legal, and workers’ compensation insurance sectors. The company supports a wide customer base ranging from individual healthcare professionals and institutions to companies producing medical devices, pharmaceuticals, biologics, and life sciences products. Its product coverage extends to clinical trials, medical devices such as orthopedic implants and diagnostic instruments, and pharmaceuticals including branded and generic drugs. ProAssurance leverages advanced technologies including artificial intelligence and data analytics to optimize underwriting, claims management, and cost control initiatives. ProAssurance operates primarily in the United States and interacts with a wide distribution network of independent agents as well as direct business development to meet the evolving needs of its clients. It has established strategic vendor relationships to mitigate medical claim costs, including preferred provider networks and prescription drug programs. The company is recognized for its financial strength, expertise in specialty liability insurance, and commitment to innovation in underwriting and claims processes. Overall, ProAssurance Corporation delivers specialized insurance products and services focused on professional liability within healthcare and related industries, significantly reinforced by its pending acquisition by The Doctors Company which will broaden its reach and resource base in the medical professional liability insurance market. The company remains headquartered in Birmingham, Alabama, with operations spanning across the United States. This recent acquisition and ongoing innovation mark the most significant recent changes in its business profile and strategic direction.
Verici Dx Announces Publication Validating Pre-Transplant Gene Signature Test for Predicting Early Acute Rejection in Kidney Transplant Recipients
ProAssurance Q1 Earnings Meet Estimates on Declining Expenses
ProAssurance (PRA) Matches Q1 Earnings Estimates
ProAssurance (PRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
ProAssurance Reports Results for First Quarter 2026
Hanover Insurance Group (THG) Surpasses Q1 Earnings Estimates
Skyward Specialty Insurance (SKWD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
ProAssurance (PRA) Earnings Expected to Grow: What to Know Ahead of Q1 Release
JPMorgan Chase & Co. Purchases 58,382 Shares of ProAssurance Corporation $PRA
All You Need to Know About ProAssurance (PRA) Rating Upgrade to Strong Buy
ProAssurance (PRA) Up 0.9% Since Last Earnings Report: Can It Continue?
Best Low-Beta Stocks to Own Right Away: AGRO, PRA, E & LQDA
What Makes ProAssurance (PRA) a Strong Momentum Stock: Buy Now?
ProAssurance Corporation (NYSE:PRA) Given Average Recommendation of “Reduce” by Analysts
ProAssurance Q4 Earnings Beat Estimates on Declining Expenses
Compared to Estimates, ProAssurance (PRA) Q4 Earnings: A Look at Key Metrics
ProAssurance (PRA) Q4 Earnings and Revenues Surpass Estimates
ProAssurance Reports Results for Fourth Quarter and Full-Year 2025
Credit Industriel ET Commercial Sells 80,720 Shares of ProAssurance Corporation $PRA
ProAssurance Corporation (NYSE:PRA) Receives Consensus Recommendation of “Reduce” from Analysts